AURA

Aura Biosciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 0/10
  • Momentum 3/10
Aura Biosciences sales and earnings growth
AURA Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y -12.14%
  • FCF Y/Y -19.17%
Aura Biosciences gross and profit margin trends
AURA Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -82.30%
Aura Biosciences net debt vs free cash flow
AURA Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage NA

Aura Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗